Hyperfine, Inc. (HYPR)
| Market Cap | 64.57M |
| Revenue (ttm) | 13.26M |
| Net Income (ttm) | -41.01M |
| Shares Out | 72.95M |
| EPS (ttm) | -0.57 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 146,976 |
| Open | 0.920 |
| Previous Close | 0.930 |
| Day's Range | 0.881 - 0.930 |
| 52-Week Range | 0.761 - 1.390 |
| Beta | 0.85 |
| Analysts | Hold |
| Price Target | 1.60 (+80.77%) |
| Earnings Date | Nov 12, 2024 |
About HYPR
Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut. [Read more]
Financial Performance
In 2023, Hyperfine's revenue was $11.03 million, an increase of 61.90% compared to the previous year's $6.81 million. Losses were -$44.24 million, -39.54% less than in 2022.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for HYPR stock is "Hold" and the 12-month stock price forecast is $1.6.
News
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces global expansion of commercial operations into Turkey, Israel and Saudi Arabia to support Swoop® system expansion plans.
Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine highlights data and conclusions from eleven abstracts presented at the Radiological Society of North America 2024 Annual Meeting in Chicago.
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals
GUILFORD, Conn.--(BUSINESS WIRE)--Strategic appointments position Hyperfine to drive the adoption of the Swoop® system in hospital settings and expand into the office setting.
Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body
GUILFORD, Conn.--(BUSINESS WIRE)--The new MRI standards by the IAC, effective immediately, now include portable MR scanning at the point of care.
Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces ten scientific abstracts highlighting ultra-low-field imaging will be presented at the RSNA 2024 Annual Meeting.
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the BTIG Digital Health Forum on November 25, 2024 and the Mizuho Healthcare Conference on December 11, 2024.
Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and CEO Brett Hale - Chief Admi...
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results
GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portab...
Hyperfine Announces European Launch with CE Approval
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces CE approval of its latest generation of AI-powered Swoop® system software under the European Medical Device Regulation.
Hyperfine Announces Alzheimer's Research with Promising Swoop® System Data and Advanced Image Quality
MADRID--(BUSINESS WIRE)--Hyperfine, Inc. announced the presentation of additional research data and images using the Swoop® system to image patients with Alzheimer's disease.
Hyperfine, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces that it will report financial results for the third quarter 2024 on Tuesday, November 12, 2024.
Hyperfine Swoop® Portable MR Imaging® System Utilized in Multicenter SAFE MRI ECMO Study Published in the September 29th Issue of Circulation
GUILFORD, Conn.--(BUSINESS WIRE)--Investigators at Johns Hopkins Hospital and the University of Texas-Houston publish study using the Swoop® system for patients on ECMO support.
Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care
PARIS--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain ...
Researchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (...
Hyperfine, Inc. (HYPR) Q2 2024 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - C...
Hyperfine Announces Presentation of Initial Data from Observational Clinical Studies Evaluating the Use of Portable MR Brain Imaging for Alzheimer's Patients
PHILADELPHIA--(BUSINESS WIRE)--Hyperfine presents initial data from observational clinical studies evaluating the use of portable MR brain imaging for Alzheimer's patients.
Hyperfine Announces FDA Clearance of Software Update That Enables Faster Acquisition of Best-in-Class Ultra-Low-Field Brain Images
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces FDA clearance of software update that enables faster acquisition of best-in-class ultra-low-field Brain Images.
Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to announce second quarter 2024 financial results on August 8, 2024.
Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine expands European market reach with additional strategic distributor partners.
Clinical Research Using Swoop® System for Alzheimer's Disease Monitoring to be Presented at the 2024 Alzheimer's Association International Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Clinical research using Swoop® system for Alzheimer's disease monitoring to be presented at the 2024 AAIC.
Hyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to host analyst and investor education webcast with clinical and brain imaging experts on June 25, 2024.
Hyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to India
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. continues global expansion by entering into distribution partnership with Radiosurgery Global, Ltd. to bring Swoop® system to India.
Hyperfine, Inc. to Present at the Jefferies Global Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the Jefferies Global Healthcare Conference.
Hyperfine, Inc. Celebrates ASNR 2024
LAS VEGAS--(BUSINESS WIRE)--The 2024 ASNR Annual Meeting had a strong focus on Alzheimer's disease care and growing excitement about ultra-low-field MRI.
Hyperfine, Inc. (HYPR) Q1 2024 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR) Q1 2024 Earnings Conference Call May 13, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group, Investor Relations Maria Sainz - President and Chief Execut...